Fig. 3: Berzosertib plasma concentration–time profiles (PK analysis set).

a Single ascending doses of berzosertib for the lead-in period (berzosertib monotherapy). b Berzosertib + gemcitabine and berzosertib + gemcitabine + cisplatin cohorts. StD standard deviation.